维普中文期刊产品整合服务
25篇 您的检索式:作者名="Matthan NR"
    题名 作者 年代 出处 被引量
1Compari- son of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers 显示文摘van Himbergen TM Matthan NR Resteghini NA 2009J Lip- id Res2009,50,4:1
2Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers显示文摘van Himbergen TM Matthan NR Resteghini NA 2009J Lipid Res2009,50,:1
3Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers显示文摘van Himbergen TM Matthan NR Resteghini NA 2009Lipid Res2009,50,73:1
4Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers显示文摘van Himbergen TM Matthan NR Resteghini NA 0,,04:1
5Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy:insights from the PROSPER trial显示文摘Matthan NR Resteghinv N Robertson M 2010J Lipid Res2010,51,1:1
6Long-term fatty acid stability in human serum cholesteryl ester,triglyceride,and phospholipid fractions显示文摘Matthan NR Ip B Resteghini N 2010J Lipid Res2010,51,9:1
7Regulation of ATP-binding cassette transporters and cholesterol efflux by glucose in primary human monocytes and murine bone marrow-derived macrophages显示文摘Spartano NL Lamon-Fava S Matthan NR 2014Exp Clin Endocrinol Diabetes2014,122,8:1
8Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice显示文摘Wang S Miller B Matthan NR 2013Nutr Res2013,33,12:1
9Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD 显示文摘Erkkila AT Matthan NR Herrington DM 2006J Lipid Res2006,47,12:1
10Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee:the MOST study显示文摘Baker KR Matthan NR Lichtenstein AH 2012Osteoarthritis Cartilage2012,20,5:1
11Alterations in choles- terol absorption/synthesis markers characterize Framingham off- spring study participants with C HD 显示文摘Matthan NR Pencina M LaRocque JM 2009J Lipid Res2009,50,9:1
12Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers显示文摘Van Himbergen TM Matthan NR NA Resteghini 2009J Lipid Res2009,50,:1
13Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolemic postmenopausal women显示文摘Vega-López S Matthan NR Ausman LM Ai M Otokozawa S Schaefer E J Lichtenstein AH 0,,01:1
14Higher plasma docosahexaeno- ic acid is associated with reduced progression of coronary atherosclerosis in women with CAD显示文摘Erkkila AT Matthan NR Herrington DM 2006J Lipid Res2006,47,12:1
15Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice显示文摘Wang S Miller B Matthan NR 2013Nutr Res2013,33,12:1
16Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women显示文摘Matthan NR Welty FK Barrett PH Haransz C Dolnikowski GG Parks JS Eckel RH Schaefer EJ Lichtenstein AH 0,,06:1
17Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers 显示文摘van Himbergen TM Matthan NR Resteghini NA 2009J Lipid Res2009,50,4:1
18Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers显示文摘van Himbergen TM Matthan NR Resteghini NA 2009J Lipid Res2009,50,4:1
19Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers 显示文摘van Himbergen TM Matthan NR Resteghini N A 2009J Lipid Res2009,50,4:1
20Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers显示文摘van Himbergen TM Matthan NR Resteghini NA 2009J Lipid Res2009,50,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费